- Home
- ETY vs AMRX Comparison
ETY vs AMRX Comparison
Compare ETY & AMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ETY
- AMRX
- Stock Information
- Founded
- ETY 2006
- AMRX 2002
- Country
- ETY United States
- AMRX United States
- Employees
- ETY N/A
- AMRX N/A
- Industry
- ETY Finance Companies
- AMRX Biotechnology: Pharmaceutical Preparations
- Sector
- ETY Finance
- AMRX Health Care
- Exchange
- ETY Nasdaq
- AMRX Nasdaq
- Market Cap
- ETY 2.3B
- AMRX 2.7B
- IPO Year
- ETY N/A
- AMRX N/A
- Fundamental
- Price
- ETY $14.88
- AMRX $8.36
- Analyst Decision
- ETY
- AMRX Strong Buy
- Analyst Count
- ETY 0
- AMRX 5
- Target Price
- ETY N/A
- AMRX $10.00
- AVG Volume (30 Days)
- ETY 247.3K
- AMRX 1.1M
- Earning Date
- ETY 01-01-0001
- AMRX 11-08-2024
- Dividend Yield
- ETY 7.21%
- AMRX N/A
- EPS Growth
- ETY N/A
- AMRX N/A
- EPS
- ETY N/A
- AMRX N/A
- Revenue
- ETY N/A
- AMRX $2,680,420,000.00
- Revenue This Year
- ETY N/A
- AMRX $17.56
- Revenue Next Year
- ETY N/A
- AMRX $3.23
- P/E Ratio
- ETY N/A
- AMRX N/A
- Revenue Growth
- ETY N/A
- AMRX 12.32
- 52 Week Low
- ETY $10.59
- AMRX $4.16
- 52 Week High
- ETY $13.46
- AMRX $9.48
- Technical
- Relative Strength Index (RSI)
- ETY 57.37
- AMRX 44.27
- Support Level
- ETY $14.75
- AMRX $8.11
- Resistance Level
- ETY $15.01
- AMRX $8.47
- Average True Range (ATR)
- ETY 0.20
- AMRX 0.37
- MACD
- ETY 0.00
- AMRX -0.05
- Stochastic Oscillator
- ETY 61.10
- AMRX 42.97
About ETY Eaton Vance Tax-Managed Diversified Equity Income Fund of Beneficial Interest
Eaton Vance Tax-mgd Dvsf Eq Inc Fd is a diversified, closed-end management investment company. Its primary investment objective is to provide current income and gains. The secondary objective of the fund is capital appreciation. Its portfolio of investments consists of capital markets, banks, internet and direct marketing retail, biotechnology, media, oil, gas, and consumable fuels, and other sectors.
About AMRX Amneal Pharmaceuticals Inc.
Amneal Pharmaceuticals Inc is a global pharmaceutical company operating primarily in the U.S., India, and Ireland. With three reportable segments; Generics, Specialty, and AvKARE - It develop, manufacture, and distribute a diverse portfolio of essential medicines. The Generics segment focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.